Top News

Kejriwal meets boy suffering from rare genetic disorder SMA

Delhi Chief Minister Arvind Kejriwal on Tuesday met an 18-month-old boy suffering from a rare genetic disease SMA (Spinal Muscular Atrophy) to inquire about his health. The boy, Kanav, was afflicted with the genetic Spinal Muscular Atrophy (SMA) disease that affects the nerve cells that control voluntary muscles. SMA is caused by a deficiency of the SMN-1 gene in the body. 

The family had raised the funds for his treatment through crowdfunding. Mr Kejriwal said that the family had needed a Rs. 17.5 crore injection, which had to be imported from the United States. With the efforts of MPs Sanjeev Arora and Sanjay Singh and the support of the public, this injection has been administered to Kanav, he said.

“After various efforts and research, Kanav’s parents were told that there was only one cure, one injection to ameliorate Kanav’s condition which would be brought from the USA. This injection would cost a whopping Rs.17.5 crores because this is a rare disease. In the entire country, there have been only 9 such cases and this is the first case in Delhi,” Chief Minister informed on the occasion.

Mr Kejriwal said Rs 10.5 crore was raised through crowdfunding and the drug was brought from the US. “With all these valiant contributions and efforts, Kanav’s parents could accumulate Rs. 10.5 crores only. Then they called the injection company illustrating their finances and the company acknowledged that and offered the injection at Rs.10.5 crores. We want to thank the company as well”, he added.

The chief minister thanked all those who donated money, including some celebrities and MPs, for the costly injection. He also thanked the US-based drug manufacturer, saying it agreed to sell the medicine for Rs 10.5 crore. Kejriwal also thanked the Centre for exempting the medicine from import duty. After the treatment, Kanav’s situation has improved and he can sit and move his limbs, he said.

Medlarge

Recent Posts

Kailash IVF marks one year of delivering advanced, personalized fertility care

Kailash IVF, the fertility centre under Kailash Healthcare, has completed asuccessful year of providing advanced,…

3 weeks ago

Breakthrough Defence technology SSI Vimana and Project Operion launched

 SS Innovations International, the maker of India’s first and only home-grown surgical robotic system, SSI…

3 weeks ago

Ayurvedic wellness brand Amma Living launched to bring traditional wisdom into everyday life

An Ayurvedic preventive wellness brand - Amma Living – has made its entry into India’s…

1 month ago

Cancer Awareness, Prevention and Screening camp held at Tis Hazari Court Complex

In an effort to promote early detection and prevention of deadly cancer among court staffs,…

2 months ago

Over 90% Glaucoma cases undiagnosed in India, experts at AbbVie Conclave

Nearly 90 per cent of glaucoma cases in India remain undiagnosed, experts warned at a…

2 months ago

Common among women of reproductive age-group, AIIMS warns of rising prevalence of autoimmune disease

The All India Institute of Medical Sciences on Wednesday flagged concern over a spurt in…

4 months ago